Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 23 February 2018

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Incidence of irritable bowel syndrome and functional bowel disorders after bacillary dysentery

The incidence of irritable bowel syndrome and functional bowel disorders after bacillary dysentery has been evaluated in a study published in the latest edition of the journal Gut.

News image

fiogf49gjkf04

Professor G-Z Pan and colleagues from the Department of Gastroenterology at the Chinese Academy of Medical Sciences in Beijing, China, were interested to find out more about the pathogenesis of post-infective irritable bowel syndrome (IBS), about which little is known.

Therefore, they investigated the incidence of IBS and functional bowel disease (FBD) in a Chinese patient population who had recovered from bacillary dysentery.

They also examined the relationship between mast cells and intestinal nerves, as well as examining neuroimmunological changes in interleukins, mast cells and neuropeptides, in order to further understand its pathogenesis.

The researchers studied a cohort of 295 patient who had recovered from bacillary dysentery, 71.4% of whom had shigella identified from stool samples, as well as 243 control subjects. These consisted of patient siblings or spouses who had not been infected with bacillary dysentery.

Using questionnaires, all subjects were followed-up for 1 to 2 years in order to identify the incidence of FBD and IBS, as defined by the Rome II criteria.

Bacillary dysentery is a causative factor in post-infective IBS
Gut

In 56 cases of IBS, both post-infective and non post-infective, the numbers of mast cells in biopsy specimens from the intestinal mucosa were counted under light microscopy, following staining with anti-tryptase antibody.

In addition, the relationship of mast cells to neurone specific enolase (NSE), substance P (SP), 5-hydroxytryptamine (5-HT), or calcitonin gene related peptide positive nerve fibers was observed using double staining with alcian blue and neuropeptide antibodies.

In 30 cases of IBS (half of which were post-infective), taken randomly from the 56 cases of IBS in total, expression of interleukin (IL)-1, IL-1ß, and IL-1 receptor antagonist (IL-1ra) mRNAs in intestinal mucosa were identified using reverse transcription-polymerase chain reaction.

All the results were compared with 12 non-IBS controls.

The results showed that in the group of bacillary dysentery-infected patients, the incidences of FBD and IBS were 22.4% and 8.1%. In those who had provided stool samples positive for shigella, the incidence of IBS rose to 10.2%.

In the control group the levels of FBD and IBS were considerably lower, at 7.4% and 0.8% respectively.

The researchers found that a longer duration of diarrhea (7 days) was associated with a higher risk of developing FBD, while expression of IL-1ß mRNA in the terminal ileum and rectosigmoid mucosa was significantly higher in post-infective IBS patients.

The number of mast cells in the terminal ileum mucosa in post-infective IBS (11.19) and non-post-infective IBS patients (10.78) was significantly increased compared with that in control subjects (6.05).

Also, in the terminal ileum and rectosigmoid mucosa of IBS patients, the density of NSE, SP, and 5-HT positively stained nerve fibers increased and appeared in clusters, surrounding an increased number of mast cells compared with controls.

Commenting on their findings, Professor Pan said they showed that bacillary dysentery is a causative factor in post-infective IBS. He added that both the immune system and the nervous system may play important roles in the pathogenesis of post-infective IBS.

Gut 2004; 53 (8): 1096 - 1101
15 July 2004

Go to top of page Email this page Email this page to a colleague

 23 February 2018 
Patients on antithrombotic agents undergoing emergency and elective endoscopy
 23 February 2018 
Heavy metals on a gluten-free diet
 23 February 2018 
MRI and NAFLD
 22 February 2018 
Outcomes with Crohn’s after infliximab withdrawal
 22 February 2018 
Elderly onset of IBD

 22 February 2018 
Autophagy enhancers
 21 February 2018 
Management of hemorrhoids in the USA
 21 February 2018 
Adalimumab and infliximab in biologic-naïve Crohn's
 21 February 2018 
Cystic fibrosis and colorectal cancer
 20 February 2018 
Complications and surveillance colonoscopies
 20 February 2018 
Treatment algorithm for polyp cancers
 20 February 2018 
Predictors of postoperative infection in Crohn's
 19 February 2018 
Screening colonoscopy in the right and left colon
 19 February 2018 
NAFLD prevalence in the USA
 19 February 2018 
Fructans in children with IBS

 16 February 2018 
Inflammatory bowel diseases are global diseases
 16 February 2018 
Undetected celiac in the elderly
 16 February 2018 
Fructans induce non-celiac gluten sensitivity
 15 February 2018 
NSAIDS and GI damage
 15 February 2018 
Oral direct-acting antiviral treatment for Hep C virus genotype 1
 15 February 2018 
Primary vs secondary surgery for the presence of lymph node metastasis
 14 February 2018 
Predicting adenoma detection rate
 14 February 2018 
Normal bowel frequency characterization in the USA 
 13 February 2018 
Personalising treatment options for IBS
 13 February 2018 
Prebiotics improve endothelial dysfunction
 13 February 2018 
Diagnostic criteria for a Rome IV functional gastrointestinal disorders
 12 February 2018 
Visceral hypersensitivity and functional GI disorders
 12 February 2018 
Depression and aggressive IBD
 12 February 2018 
Variability in interpretation of endoscopic findings impacts patient management
 09 February 2018 
Treatment of choice for anastomotic stricture in IBD
 09 February 2018 
PRO measurement information system 
 09 February 2018 
Overall disease severity indices for IBD
 08 February 2018 
Prediction of endoscopically active disease

 08 February 2018 
Steroid-refractory acute severe ulcerative colitis
 08 February 2018 
Decision aid used by IBD patients
 07 February 2018 
Ursodeoxycholic acid combined with bezafibrate for itching
 07 February 2018 
Change in microbiome in gastritis vs gastric carcinoma
 07 February 2018 
Colorectal cancer and primary sclerosing cholangitis-IBD
 06 February 2018 
Risk of death after liver transplantation
 06 February 2018 
Crohn’s disease vs refractory pouchitis
 06 February 2018 
Support for functional dyspepsia symptom diary
 05 February 2018 
Helicobacter spp influence on GI tract 
 05 February 2018 
No link found between severe reflux and all-cause mortality 
 05 February 2018 
Psychological distress in PPI non-responders
 02 February 2018 
Assessing psychosexual impact of IBD
 02 February 2018 
Decrease in overall mortality with cholera vaccination
 02 February 2018 
Diagnostic performance of fecal immunochemical tests
 01 February 2018 
Screening frequency with family histories of colorectal cancer
 01 February 2018 
IBD and sport participation
 01 February 2018 
Life with a stoma 
 31 January 2018 
Aprepitant and gastroparesis 
 31 January 2018 
Anesthesia risk in colonoscopy
 31 January 2018 
GED-0301 for Crohn's Disease
 30 January 2018 
Intestinal dysbiosis and allergic diseases in infants
 30 January 2018 
Fructans and IBS symptoms in children
 29 January 2018 
Dosing calculator for therapy optimization in IBD
 29 January 2018 
Glecaprevir–pibrentasvir for in HCV
 29 January 2018 
Food allergen injections in eosinophilic esophagitis
 29 January 2018 
Reliability of the IBD index
 26 January 2018 
Tofacitinib vs biological therapies for ulcerative colitis

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us